Laboratory-Confirmed COVID-19 Case Incidence Rates Among Residents in Nursing Homes by Up-to-Date Vaccination Status — United States, October 10, 2022–January 8, 2023
Weekly / January 27, 2023 / 72(4);95–99
Heather Dubendris, MSPH1,2; Hannah E. Reses, MPH1; Emily Wong, MPH1; Phillip Dollard, MPH1; Minn Soe, MBBS1; Meng Lu, PhD1; Jonathan R. Edwards, MStat1; Tamara Pilishvili, PhD3; Theresa Rowe, DO1; Andrea Benin, MD1; Jeneita M. Bell, MD1 (View author affiliations)View suggested citation
What is already known about this topic?
COVID-19 vaccines are effective against SARS-CoV-2 infection in nursing home residents; however, the impact of recently recommended vaccinations, including bivalent booster doses, in this population is unknown.
What is added by this report?
Nursing home residents who were not up to date with recommended COVID-19 vaccines had a 30%–50% higher risk for acquiring SARS-CoV-2 infection compared with residents who were up to date with COVID-19 vaccines.
What are the implications for public health practice?
This study supports other recent findings that the bivalent booster dose offers additional protection in persons who previously received monovalent vaccines. Nursing home residents can maximize protection against COVID-19 by receiving bivalent COVID-19 booster doses to stay up to date with recommended COVID-19 vaccinations.
Views equals page views plus PDF downloads
Nursing home residents have been disproportionately affected by COVID-19; older age, comorbidities, and the congregate nature of nursing homes place residents at higher risk for infection and severe COVID-19–associated outcomes, including death (1). Studies have demonstrated that receipt of a primary COVID-19 mRNA vaccination series (2) and monovalent booster doses (3) is effective in reducing COVID-19–related morbidity and mortality in this population. Public health recommendations for staying up to date with COVID-19 vaccination have been revised throughout the pandemic response, most recently to include an updated (bivalent) booster dose, which protects against both the ancestral strain of SARS-CoV-2 and recent Omicron variants BA.4 and BA.5 (4). However, data on the effectiveness of staying up to date, including with bivalent booster doses, are lacking among nursing home residents. CDC’s National Healthcare Safety Network (NHSN) analyzed surveillance data to examine weekly incidence rates of COVID-19 among nursing home residents by up-to-date vaccination status (receipt of a bivalent booster dose or completion of a primary series or receipt of a monovalent booster dose within the previous 2 months [i.e., not yet eligible to receive a bivalent booster dose]).* Up-to-date vaccination status among nursing home residents remained low throughout the study period, increasing to 48.9% by the week ending January 8, 2023. During October 10, 2022–January 8, 2023, the COVID-19 weekly incidence rates (new cases per 1,000 nursing home residents) among residents who were not up to date with COVID-19 vaccination were consistently higher than those among residents who were up to date. Moreover, the weekly incidence rate ratios (IRRs) indicated that residents who were not up to date with COVID-19 vaccines had a higher risk for acquiring SARS-CoV-2 than their up-to-date counterparts (IRR range = 1.3–1.5). It is critical that nursing home residents stay up to date with COVID-19 vaccines and receive a bivalent booster dose to maximize protection against COVID-19.
Nursing homes began reporting numbers of laboratory-confirmed COVID-19 cases (a newly positive SARS-CoV-2 viral test result received by a resident) and vaccination data to NHSN in April 2020 and December 2020, respectively, and federal mandates issued by the Centers for Medicare & Medicaid Services (CMS) require CMS-certified nursing homes to report these data weekly.†,§ The method for collecting laboratory-confirmed COVID-19 case data in nursing homes has been described (2). Vaccination data collection includes the weekly number of residents in the nursing home (with a stay of ≥24 hours) stratified by vaccination status, including the number of residents who are up to date with recommended COVID-19 vaccination.
NHSN analyzed weekly COVID-19 case and vaccination status data during October 10, 2022–January 8, 2023, for CMS-certified nursing homes to assess the data collected based on NHSN’s 2022 fourth quarter (October–December) definition of up-to-date COVID-19 vaccination status.¶ The study paired weekly incident case counts by vaccination status with weekly resident counts by vaccination status for each nursing home to calculate crude COVID-19 incidence rates with 95% CIs, by up-to-date vaccination status for each reporting week. Case counts were combined with resident vaccination counts from 2 weeks earlier, because COVID-19 case vaccination status is classified according to vaccination status 14 days before receipt of a positive SARS-CoV-2 test result.
Facilities with missing case or vaccination data were excluded from the analysis. NHSN calculated IRRs by up-to-date vaccination status each week. NHSN also analyzed a subset of data from facilities voluntarily reporting dates, types, and number of primary series doses and booster doses received by each resident (rather than weekly aggregate totals) to calculate the proportion of up-to-date residents who had received a bivalent booster dose.** Analyses were performed using SAS software (version 9.4; SAS Institute). This activity was reviewed by CDC and was conducted consistent with applicable federal law and CDC policy.††
Among 16,352 nursing homes, 15,049 (92%) in the 50 U.S. states and the District of Columbia reported case and vaccination data for ≥1 week during the 13-week study period.§§ After exclusions, 192,289 facility-weeks (97%) were included in the analysis. An average of 14,791 facilities reported both COVID-19 vaccination and case data each week (range = 14,622–14,874). Facility size (the number of health care personnel per facility) varied, with a median of 116 health care personnel per facility (IQR = 82–165) (Figure). The percentage of residents with up-to-date COVID-19 vaccination status increased slightly during the study period, beginning the week of October 23, from 37.5% to 48.9%; this incremental increase was similar across all facility sizes and geographic regions.
Each week, COVID-19 incidence rates among nursing home residents who were not up to date with COVID-19 vaccination were higher than those among residents who were up to date (Table). Incidence rates among residents who were up to date with COVID-19 vaccination ranged from 7.2 per 1,000 residents (week ending November 13, 2022) to 15.6 (week ending January 8, 2023) during this period, while incidence rates among those who were not up to date ranged from 9.5 (week ending October 16, 2022) to 18.8 (weeks ending December 11, 2022, and January 8, 2023). IRRs between residents who were not up to date with COVID-19 vaccination and those who were up to date were statistically significant and ranged from 1.3 to 1.5. Among the 15,049 nursing homes included in this study, 1,759 (11.7%) voluntarily reported additional details on vaccine doses for each resident rather than weekly aggregate totals. Analysis of these data for each week of the study period indicated that >99% of residents classified as being up to date had received a bivalent booster dose.
Weekly incidence rates of COVID-19 among nursing home residents who were not up to date with COVID-19 vaccines were 30%–50% higher than were those among residents who were up to date during October 10, 2022–January 8, 2023. Among the subset of nursing homes reporting additional details on vaccine doses for each resident, almost all residents with up-to-date COVID-19 vaccination status had received a bivalent booster dose, suggesting that up-to-date vaccination status can be used to represent bivalent booster dose coverage among nursing home residents. The findings in this report are consistent with other recent studies supporting effectiveness of bivalent booster doses, including a study among adults aged ≥18 years demonstrating that bivalent booster doses maximized protection against symptomatic SARS-CoV-2 infection compared with protection from monovalent vaccination alone (5). Another recent study found that bivalent booster doses produced a robust immunologic response in nursing home residents (6). Bivalent booster doses have also been shown to provide additional protection against severe outcomes associated with COVID-19, compared with monovalent vaccination alone, including protection against COVID-19–associated emergency department and urgent care visits among adults aged ≥18 years and protection against COVID-19 hospitalization among adults aged ≥65 years (7,8). Public health efforts to sustain up-to-date COVID-19 vaccination status among nursing home residents (including recommended vaccinations and booster doses) are critical to protecting this population.
Although bivalent booster doses were recommended during fall 2022 (4), and the time to receive the bivalent booster dose and remain up to date according to current recommendations has been limited, the proportion of nursing home residents in this study who were up to date (48.9%) was lower than the percentage of nursing home residents who completed a primary series (86.1%) and who received monovalent booster doses (87.0%).¶¶ Bivalent booster doses are recommended for nursing home residents who previously received monovalent doses to stay up to date. There might be several reasons that nursing home residents have not received a bivalent COVID-19 booster dose, including the perception that additional vaccination is unnecessary because of beliefs of low booster vaccine effectiveness, misinformation about the severity of illness, or vaccination fatigue related to changes in guidance and recommendations for more doses (9,10). Access to vaccination at the facility might also have an impact.
The findings in this study are subject to at least four limitations. First, data are largely manually reported by nursing homes; therefore, misclassification of case and vaccination status of residents is possible, especially in light of changing guidance regarding what constitutes being up to date. Second, crude incidence rates and IRRs in this analysis do not account for potential nursing home or person-level confounding factors, such as time since vaccination, previous infection, age, comorbidities, community transmission rates, nursing home staff member vaccination coverage rates, or nursing home infection prevention practices. Third, the analysis did not consider residents who received a positive SARS-CoV-2 test result to be up to date with COVID-19 vaccines until 14 days after receipt of their last vaccine dose; therefore, cases among residents not up to date with COVID-19 vaccines might include infections among residents who had received a recent bivalent vaccine dose <14 days earlier. This would bias findings of difference between the two groups toward the null. Finally, the group that was not up to date comprised both unvaccinated residents and those who had received some previous vaccination but were not up to date. This precluded comparison of more specific vaccination statuses (e.g., completely unvaccinated, receipt of a complete primary series, and completed a primary series plus ≥1 monovalent booster dose) with the up-to-date group.
In this study of U.S. nursing home residents during October 2022–January 2023, differences in crude COVID-19 incidence rates among persons who were up to date with COVID-19 vaccinations and those who were not suggest that staying up to date with CDC-recommended vaccinations, which now includes receiving a bivalent booster dose, maximizes protection against COVID-19. Efforts to address barriers and increase bivalent COVID-19 booster dose coverage among nursing home residents are critical to preventing illness, severe disease, and death in this population.
Audrey Robnett-Brown, Sherese Dennard, Emily Haanschoten, Elizabeth Kalayil, Avni Patel, George Segovia, Shanjeeda Shafi, Jolie Siegel, CDC National Healthcare Safety Network Vaccination Unit Team.
Corresponding author: Heather Dubendris, email@example.com.
1Division of Healthcare Quality Promotion, National Center for Emerging and Zoonotic Infectious Diseases, CDC; 2Lantana Consulting Group, East Thetford, Vermont; 3Division of Viral Diseases, National Center for Immunization and Respiratory Diseases, CDC.
All authors have completed and submitted the International Committee of Medical Journal Editors form for disclosure of potential conflicts of interest. No potential conflicts of interest were disclosed.
†† 45 C.F.R. part 46, 21 C.F.R. part 56; 42 U.S.C. Sect. 241(d); 5 U.S.C. Sect. 552a; 44 U.S.C. Sect. 3501 et seq.
§§ U.S. territories were excluded from the analysis because of small numbers.
- Su Z, McDonnell D, Li Y. Why is COVID-19 more deadly to nursing home residents? QJM 2021;114:543–7. https://doi.org/10.1093/qjmed/hcaa343 PMID:33453109
- Bagchi S, Mak J, Li Q, et al. Rates of COVID-19 among residents and staff members in nursing homes—United States, May 25–November 22, 2020. MMWR Morb Mortal Wkly Rep 2021;70:52–5. https://doi.org/10.15585/mmwr.mm7002e2 PMID:33444301
- Prasad N, Derado G, Nanduri SA, et al. Effectiveness of a COVID-19 additional primary or booster vaccine dose in preventing SARS-CoV-2 infection among nursing home residents during widespread circulation of the Omicron variant—United States, February 14–March 27, 2022. MMWR Morb Mortal Wkly Rep 2022;71:633–7. https://doi.org/10.15585/mmwr.mm7118a4 PMID:35511708
- Rosenblum HG, Wallace M, Godfrey M, et al. Interim recommendations from the Advisory Committee on Immunization Practices for the use of bivalent booster doses of COVID-19 vaccines—United States, October 2022. MMWR Morb Mortal Wkly Rep 2022;71:1436–41. https://doi.org/10.15585/mmwr.mm7145a2 PMID:36355612
- Link-Gelles R, Ciesla AA, Fleming-Dutra KE, et al. Effectiveness of bivalent mRNA vaccines in preventing symptomatic SARS-CoV-2 infection—Increasing Community Access to Testing program, United States, September–November 2022. MMWR Morb Mortal Wkly Rep 2022;71:1526–30. https://doi.org/10.15585/mmwr.mm7148e1 PMID:36454688
- Canaday D, Oyebanji OA, White E, et al. SARS-CoV-2 antibody responses to the ancestral SARS-CoV-2 strain and Omicron BA.1 and BA.4/BA.5 variants in nursing home residents after receipt of bivalent COVID-19 vaccine—Ohio and Rhode Island, September–November 2022. MMWR Morb Mortal Wkly Rep 2022;72. Epub January 27, 2022. https://www.cdc.gov/mmwr/volumes/72/wr/mm7204a4.htm?s_cid=mm7204a4_w
- Tenforde MW, Weber ZA, Natarajan K, et al. Early estimates of bivalent mRNA vaccine effectiveness in preventing COVID-19–associated emergency department or urgent care encounters and hospitalizations among immunocompetent adults—VISION Network, nine states, September–November 2022. MMWR Morb Mortal Wkly Rep 2022;71:1616–24. https://doi.org/10.15585/mmwr.mm715152e1 PMID:36580430
- Surie D, DeCuir J, Zhu Y, et al. Early estimates of bivalent mRNA vaccine effectiveness in preventing COVID-19–associated hospitalization among immunocompetent adults aged ≥65 years—IVY Network, 18 states, September 8–November 30, 2022. MMWR Morb Mortal Wkly Rep 2022;71:1625–30. https://doi.org/10.15585/mmwr.mm715152e2 PMID:36580424
- CDC. State of vaccine confidence insights report. Atlanta, GA: US Department of Health and Human Services, CDC; 2022. https://www.cdc.gov/vaccines/covid-19/downloads/SoVC_report28.pdf
- Batra K, Sharma M, Dai C-L, Khubchandani J. COVID-19 booster vaccination hesitancy in the United States: a multi-theory-model (MTM)-based national assessment. Vaccines (Basel) 2022;10:758. https://doi.org/10.3390/vaccines10050758 PMID:35632514
FIGURE. Percentage of nursing home residents with up-to-date COVID-19 vaccination,* by U.S. region, number of health care personnel per facility,† and week§ — United States, October 10, 2022–January 8, 2023
Abbreviation: UTD = up to date with COVID-19 vaccines.
* Receipt of a bivalent booster dose or completion of a primary series or receipt of a monovalent booster dose within the previous 2 months (i.e., not yet eligible to receive a bivalent booster dose).
† Used as an estimate of facility size.
§ For each reporting week, vaccination data from 2 weeks earlier are included to allow for appropriate incidence rate calculation.
Suggested citation for this article: Dubendris H, Reses HE, Wong E, et al. Laboratory-Confirmed COVID-19 Case Incidence Rates Among Residents in Nursing Homes by Up-to-Date Vaccination Status — United States, October 10, 2022–January 8, 2023. MMWR Morb Mortal Wkly Rep 2023;72:95–99. DOI: http://dx.doi.org/10.15585/mmwr.mm7204a3.
MMWR and Morbidity and Mortality Weekly Report are service marks of the U.S. Department of Health and Human Services.
Use of trade names and commercial sources is for identification only and does not imply endorsement by the U.S. Department of Health and Human Services.
References to non-CDC sites on the Internet are provided as a service to MMWR readers and do not constitute or imply endorsement of these organizations or their programs by CDC or the U.S. Department of Health and Human Services. CDC is not responsible for the content of pages found at these sites. URL addresses listed in MMWR were current as of the date of publication.
All HTML versions of MMWR articles are generated from final proofs through an automated process. This conversion might result in character translation or format errors in the HTML version. Users are referred to the electronic PDF version (https://www.cdc.gov/mmwr) and/or the original MMWR paper copy for printable versions of official text, figures, and tables.
Questions or messages regarding errors in formatting should be addressed to firstname.lastname@example.org.